Table (5).

Relationship between METAVIR activity & fibrosis scores and laboratory data in patients CHC with elevated enzymes.

Laboratory Data	METAVIR (activity) (A)		METAVIR (staging) (F)
	r	p	r	p
FBG	0.80	0.01**	0.43	0.02*
FI	0.38	0.1*	0.60	0.01**
HOMA-IR	0.49	0.02*	0.66	0.01**
PCR	0.41	0.031*	0.32	0.22
ALT	0.42	0.04*	0.40	0.04*
PT	0.87	0.01**	0.49	0.01**

In CHC patients with normal liver enzymes; FBG & HOMA-IR were correlated with METAVIR activity and liver fibrosis scores in table (6) & figure (4) (p=0.04, 0.01 and p=0.01, 0.02 respectively) while viral load (PCR) was correlated with METAVIR activity score only (p=0.031) and prothrombin time was correlated with METAVIR fibrosis score (p=0.02). There is a correlation between serum fasting insulin and liver fibrosis progression in CHC patients with elevated enzymes (p=0.01) table (5) and in those with normal enzymes (p=0.02) (table-6).